# Hazard ratios from network meta-analysis

Source: `R/data.R`
`mstate_nma_hr.Rd`

Hazard ratios for first line treatments relative to gefitinib estimated using a Bayesian multi-state network meta-analyis (NMA).

    mstate_nma_hr

## Format

A data.table with the following columns:

line

  Line of treatment. Either first or second.

model

  The statistical model.

tx_name

  Name of the treatment.

month

  Trial month.

transition

  The health state transition.

mean

  Mean hazard ratio from the posterior distribution.

median

  Median hazard ratio from the posterior distribution.

l95

  Lower limit of 95 percent credible interval from posterior distribution.

u95

  Upper limit of the 95 percent credible interval from the posterior distribution.

## See also

`mstate_nma_surv`, `mstate_nma_hazard`

## Examples

    head(mstate_nma_hr)#>    line   model   tx_name month            transition      mean    median
    #> 1:    1 Weibull erlotinib     0 Stable to progression 1.0000000 1.0000000
    #> 2:    1 Weibull erlotinib     1 Stable to progression 0.7534282 0.6815825
    #> 3:    1 Weibull erlotinib     2 Stable to progression 0.6267102 0.5969727
    #> 4:    1 Weibull erlotinib     3 Stable to progression 0.5727375 0.5528516
    #> 5:    1 Weibull erlotinib     4 Stable to progression 0.5415394 0.5266664
    #> 6:    1 Weibull erlotinib     5 Stable to progression 0.5208545 0.5028066
    #>          l95       u95
    #> 1: 1.0000000 1.0000000
    #> 2: 0.2802687 1.5939442
    #> 3: 0.3149345 1.0758052
    #> 4: 0.3227722 0.9344328
    #> 5: 0.2962844 0.8701981
    #> 6: 0.2721158 0.8613339